Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.340 | 0.500 | 0.160 |
Stocks | 99.660 | 99.660 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.874 | 18.854 |
Price to Book | 2.993 | 4.052 |
Price to Sales | 3.711 | 4.748 |
Price to Cash Flow | 14.221 | 15.436 |
Dividend Yield | 1.118 | 0.482 |
5 Years Earnings Growth | 7.588 | 10.530 |
Number of long holdings: 106
Number of short holdings: 25
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Alnylam | US02043Q1076 | 3.31 | 149.40 | -1.20% | |
Vertex | US92532F1003 | 3.18 | 445.21 | +1.04% | |
Amgen | US0311621009 | 3.12 | 312.47 | -0.71% | |
Novartis | CH0012005267 | 3.08 | 93.37 | +0.81% | |
Biomarin Pharma | US09061G1013 | 3.04 | 77.56 | +0.77% | |
Ionis Pharma | US4622221004 | 3.02 | 37.31 | -0.82% | |
Gilead | US3755581036 | 3.02 | 67.72 | -0.21% | |
Biogen | US09062X1037 | 2.97 | 230.57 | +0.23% | |
Roche Holding Participation | CH0012032048 | 2.96 | 237.10 | +0.98% | |
Crispr Therapeutics | CH0334081137 | 2.91 | 56.22 | +0.99% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Global Income Fund D div USD hedged | 16.83B | 2.52 | 1.02 | 3.38 | ||
JPI Global Income Fund C mth USD he | 16.83B | 2.78 | 2.06 | 4.42 | ||
JPI Global Income Fund D acc USD he | 16.83B | 2.52 | 1.04 | 3.40 | ||
JPI Global Income Fund D mth USD he | 16.83B | 2.51 | 1.01 | 3.38 | ||
JPI Global Income Fund A acc USD he | 16.83B | 2.61 | 1.40 | 3.76 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review